
In the second part of this interview, Todd Harrison, Co-Chair of the FDA Group at Venable LLP, discusses how the FDA and the industry handle novel ingredients in functional foods.
Co-Chair of the FDA Group at Venable LLP

In the second part of this interview, Todd Harrison, Co-Chair of the FDA Group at Venable LLP, discusses how the FDA and the industry handle novel ingredients in functional foods.

In the first part of this interview, Todd Harrison, Co-Chair of the FDA Group at Venable LLP, shares insights into regulatory methods, GRAS notices, and nutrition facts labeling surrounding the lawsuit against David Protein.